Petmedix has announced the completion of an oversubscribed $37M (£27M) Series B financing round that will be used to advance its pipeline through clinical development. 

The investment brings two new investors into Petmedix: global technology company Tencent and Japanese corporation Kyoritsu Holdings, alongside continued support from U.